MYND Life Sciences Inc. (MYND.CN)
CAD 0.07
(-30.0%)
CAD 0.07
(-30.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | - | - | - | - | - |
| Cost of Revenue | 332.99 Thousand | 59.82 Thousand | 86.11 Thousand | - | - |
| Gross Profit | -332.99 Thousand | -59.82 Thousand | -86.11 Thousand | - | - |
| Operating Expenses | 1.47 Million | 3 Million | 4.29 Million | 56.46 Thousand | 2535.00 |
| Selling, General and Administrative Expenses | 1.19 Million | 1.82 Million | 3.12 Million | 56.46 Thousand | 2535.00 |
| Research and Development Expenses | 282.27 Thousand | 1.18 Million | 1.07 Million | - | - |
| Other Expenses | - | - | 86.11 Thousand | - | - |
| Cost and Expenses | 1.8 Million | 3.06 Million | 4.29 Million | 56.46 Thousand | 2535.00 |
| Operating Income | -1.8 Million | -3.06 Million | -4.29 Million | -56.46 Thousand | -2535.00 |
| Interest Expense | 728.41 Thousand | 662.9 Thousand | 134.88 Thousand | - | - |
| Income Tax Expense | - | -129.94 Thousand | -168.3 Thousand | - | - |
| Earnings before Tax | -1.51 Million | -3.69 Million | -4.53 Million | -56.46 Thousand | -2535.00 |
| Net Income | -1.51 Million | -3.56 Million | -4.36 Million | -56.46 Thousand | -2535.00 |
| Earnings Per Share Basic | -0.03 | -0.08 | -0.10 | -0.00 | -0.00 |
| Earnings Per Share Diluted | -0.03 | -0.08 | -0.10 | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 47.27 Million | 46.67 Million | 44.95 Million | 28.23 Million | 1.7 Million |
| Weighted Average Shares Outstanding (Diluted) | 47.26 Million | 46.67 Million | 44.95 Million | 28.22 Million | 1.7 Million |
| Gross Margin | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - |
| Profit Margin | - | - | - | - | - |
| EBITDA | -1.82 Million | -2.97 Million | -4.31 Million | - | - |
| Earnings Before Tax Margin | - | - | - | - | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 1.00 | - | - | - |
| Cost of Revenue | 60 Thousand | 653.00 | 653.00 | 20.98 Thousand | 892.00 | 60 Thousand |
| Gross Profit | -60 Thousand | -653.00 | -652.00 | -20.98 Thousand | -892.00 | -60 Thousand |
| Operating Expenses | 281.77 Thousand | 220.57 Thousand | 333.77 Thousand | 1.81 Million | 390.99 Thousand | 254.44 Thousand |
| Selling, General and Administrative Expenses | 221.74 Thousand | 220.57 Thousand | 182.55 Thousand | - | 205.37 Thousand | 213.44 Thousand |
| Research and Development Expenses | - | - | 151.22 Thousand | - | 182.27 Thousand | - |
| Other Expenses | 60.03 Thousand | - | - | -3340.00 | -3340.00 | 21.00 |
| Cost and Expenses | 341.77 Thousand | 221.23 Thousand | 334.43 Thousand | 1.83 Million | 391.89 Thousand | 314.44 Thousand |
| Operating Income | -341.77 Thousand | -221.23 Thousand | -334.43 Thousand | -1.83 Million | -391.89 Thousand | -314.42 Thousand |
| Interest Expense | 37.5 Thousand | 38.33 Thousand | 38.33 Thousand | 728.41 Thousand | 120.91 Thousand | 216.35 Thousand |
| Income Tax Expense | -82.00 | -3.00 | -3.00 | 4.00 | -2.00 | 216.37 Thousand |
| Earnings before Tax | -379.27 Thousand | -259.56 Thousand | -372.76 Thousand | -1.51 Million | 469.03 Thousand | -530.77 Thousand |
| Net Income | -379.27 Thousand | -259.56 Thousand | -372.76 Thousand | -1.51 Million | 469.03 Thousand | -530.77 Thousand |
| Earnings Per Share Basic | -0.01 | -0.01 | -0.01 | - | 0.01 | -0.01 |
| Earnings Per Share Diluted | -0.01 | -0.01 | -0.01 | - | 0.01 | -0.01 |
| Weighted Average Shares Outstanding | 46.27 Million | 46.27 Million | 47.04 Million | 47.26 Million | 47.81 Million | 47.04 Million |
| Weighted Average Shares Outstanding (Diluted) | 46.27 Million | 46.27 Million | 47.04 Million | 47.26 Million | 47.81 Million | 47.04 Million |
| Gross Margin | - | - | -652.00 | - | - | - |
| EBIT Margin | - | - | -333.78 Thousand | - | - | - |
| Profit Margin | - | - | -372.76 Thousand | - | - | - |
| EBITDA | -341.69 Thousand | -220.58 Thousand | -333.78 Thousand | - | -391 Thousand | -313.53 Thousand |
| Earnings Before Tax Margin | - | - | -334.43 Thousand | - | - | - |
6060
5271
DB
CMFV
PARADEEP
5137